Overexpression of ENO1 was proved to be correlated with poor prognosis in various types of cancers including breast cancer [25], gastric cancer [26], bladder cancer [27], glioma [14] and non-small cell lung cancer [28]. Here, ENO1 is linked to breast cancer.